Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists

Circulation Research

Volumn 89, Issue 1, 2001, Pages 92-98

  Hamilton, Justin R ^a   Frauman, Albert G ^a   Cocks, Thomas M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Endothelium; Human coronary arteries; Protease activated receptors

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 4; RECOMBINANT INTERLEUKIN 1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0035816730     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh1301.092661     Document Type: Article

References (40)

1. Protease-activated receptors: Sentries for inflammation?
2. Thrombin signalling and protease-activated receptors
3. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases
4. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
5. Thrombin receptor activation: Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative liganding mode
6. Protease-activated receptor 3 is a second thrombin receptor in humans
7. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2
8. Interactions of mast cell tryptase with thrombin receptors and PAR-2
9. Identification of potential activators of proteinase-activated receptor-2
10. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
11. Cathepsin G activates protease-activated receptor-4 in human platelets
12. Cloning and characterization of human protease-activated receptor 4
13. PAR3 is a cofactor for PAR4 activation by thrombin
14. Increased expression of protease-activated receptor-2 (PAR-2) in balloon-injured rat carotid artery
15. Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo
16. Delayed onset of inflammation in protease-activated receptor-2-deficient mice
17. Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells
18. Protease activated receptors modulate aortic vascular tone
19. Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries
20. Identification of thrombin receptors in rat brain capillary endothelial cells
21. Proteinase-activated receptor 4 (PAR4): Action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2
22. Thrombin receptor expression in normal and atherosclerotic human arteries
23. Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro
24. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries
25. Differential expression of functional protease-activated receptor-2 (PAR-2) in human vascular smooth muscle cells
26. Induction of vascular smooth muscle cell growth by selective activation of the proteinase activated receptor-2
27. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells
28. Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo
29. The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: A link to the pathogenesis of Graves' ophthalmopathy
30. Pharmacological reactivity of human epicardial coronary arteries: Characterization of relaxation responses to endothelium-derived relaxing factor
31. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: Activation of PAR2 by PAR1-targeted ligands
32. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies
33. Endothelium-dependent responses in hypertension
34. Relationship between endothelial function and fibrinolysis in early hypertension
35. Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation
36. Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f] quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist
37. The human proteinase-activated receptor-3 (PAR-3) gene: Identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets
38. Cytokines and reperfusion injury
39. Cytokines and smooth muscle cells in atherosclerosis
40. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension